Hit enter to search or ESC to close
Astante TherapeuticsAstante Therapeutics
  • Home
  • Team
  • Pipeline
  • Technology
    • Articles & News
  • Contact Us
  • Home
  • Team
  • Pipeline
  • Technology
    • Articles & News
  • Contact Us

Recent Posts

  • An Enzyme‐Directed Imidazoquinoline for Cancer Immunotherapy
  • Comparing the immunogenicity of glycosidase-directed resiquimod prodrugs mediated by cancer cell metabolism
  • An Enzyme-Directed Imidazoquinoline Activated by Drug Resistance

© 2022 Astante Therapeutics.

  • Home
  • Team
  • Pipeline
  • Technology
    • Articles & News
  • Contact Us